Codagenix-Serum Join Fray To Develop SARS-CoV-2 Vaccine

 
• By Vibha Ravi

Codagenix, a company backed by Novartis, Merck and the Bill & Melinda Gates Foundation, has tied up with India’s Serum Institute to develop a vaccine against SARS-CoV-2, joining a heated race against the dreaded COVID-19 outbreak.

Coronavirus_Microscopic
War Against SARS-CoV-2 Sees Several Alliances • Source: Shutterstock

More from R&D

More from Scrip